z-logo
open-access-imgOpen Access
Identification of a human intestinal myeloid cell subset that regulates gut homeostasis
Author(s) -
Soumik Barman,
Hisako Kayama,
Daisuke Okuzaki,
Takayuki Ogino,
Hideki Osawa,
Hiroshi Matsuno,
Tsunekazu Mizushima,
Masaki Mori,
Junichi Nishimura,
Kiyoshi Takeda
Publication year - 2016
Publication title -
international immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.86
H-Index - 134
eISSN - 1460-2377
pISSN - 0953-8178
DOI - 10.1093/intimm/dxw034
Subject(s) - immunology , biology , cd80 , cd86 , intestinal mucosa , myeloid , t cell , cd14 , microbiology and biotechnology , immune system , innate immune system , cd40 , cytotoxic t cell , medicine , in vitro , biochemistry
Inappropriate activation of T helper (Th) cells, such as Th1 and Th17 cells, is implicated in the pathogenesis of chronic inflammatory disorders including ulcerative colitis (UC). CX 3 CR1 high macrophages contribute to intestinal homeostasis through various mechanisms in mice. However, whether mononuclear phagocytes with regulatory functions are present in the human colon is not clearly defined. We investigated whether innate myeloid cells that suppress activation of effector T cells exist in the human intestinal mucosa. Among intestinal lamina propria cells, Lin - HLA-DR high CD14 + CD163 high cells were subdivided into CD160 low and CD160 high cells. Both subsets produced high levels of IL-10. CD163 high CD160 high cells suppressed effector T cell proliferation, whereas CD163 high CD160 low cells induced Th17 differentiation. Patients with UC exhibited increased numbers of CD163 high CD160 low cells, while showing profoundly decreased numbers of CD163 high CD160 high cells. In this context, CD163 high CD160 high cells had higher CD80/CD86 expression and lower IL10RB expression, and these cells did not suppress effector T cell proliferation. The CD163 high CD160 high subset in normal intestinal mucosa inhibits inappropriate Th1/Th17 responses through suppression of their proliferation, and its number and suppressive activity are impaired in patients with UC. These findings indicate how human innate immune cells might prevent UC development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom